Company: LHI
Filing Date: 2025-02-14
Form Type: DRS/A
Source: 0001213900-25-014190
Chunk: 20

Company: Living Homeopathy International Ltd.
Filing Date: 2025-02-14
Form: DRS/A
Chunk 20
---
.                                              |

| ● | We                                                                                         
 have not finally determined the use of the proceeds from this offering, and we may use the 
 proceeds in ways with which you may not agree. See more detailed discussion of this risk   
 factor on page 46 of this prospectus.                                                      |

| ● | We                                                                                       
 may be classified as a passive foreign investment company, which could result in adverse 
 U.S. federal income tax consequences to U.S. Holders of our Class A Ordinary Shares. See 
 more detailed discussion of this risk factor on page 46 of this prospectus.              |

Corporate History and Holding Company Structure We are an exempted company incorporated with limited liability under the laws of the Cayman Islands on May 7, 2024 with operations conducted through primarily our Hong Kong subsidiary, Living Homeopathy Hong Kong. The Company was incorporated in connection with a reorganization for the proposed initial public offering. The Company has 50,000 authorized shares with a par value of $1 per share. On May 7, 2024, on its date of incorporation, the Company allotted and issued one share to LTO Holdings Limited (“LTO”), a BVI company controlled by Mr. To. On May 27, 2024, Living Homeopathy Global Limited (“Living Global”) was incorporated in BVI with limited liability and 50,000 authorized shares at $1 per share. On its date of incorporation, Living Global allotted and issued one share to the Company at $1. Upon completion of such allotment and issue of share of Living Global to the Company, Living Global became a direct wholly-owned subsidiary of the Company. On August 28, 2024, shareholder resolution of the Company was passed and approved and the article of association of the Company was amended that (i) the number of authorized shares increased from 50,000 shares to 500,000,000 shares and divided into 450,000,000 Class A Ordinary Shares and 50,000,000 Class B Ordinary Shares; and (ii) the par value of the shares decreased from $1 each to $0.0001 each (collectively refer as the “Share Re-classification”). One Class A Ordinary Share represents one voting right and one Class B Ordinary Share represents fifteen voting rights. The authorized share capital of the Company remained unchanged at $50,000. The one issued ordinary share held by LTO was reclassified as 10,000 Class A Ordinary Share upon the Share Re-classification. Pursuant to board resolution